← Back to Nascent Pharma Holdings Stock
Nascent Pharma Holdings (NASC) News
The Patents Term – Presumed Valid By Law – Extends to 2035 HICKSVILLE, NY, March 11, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Can B Corp., a Florida corporation ( OTCQB: CANB ) (“Can B”), a health and wellness company specializing in developing, producing and selling hemp-derived cannabinoid products, is pleased to announce that it has secured ownership and control of two cannabis patents that were valued at $122 million, applying a 90% discount and assuming a revenue stream through August 2034, and further based on only CBD claims and only in the U.S. It is believed that if the global THC and CBD markets were added to the valuation, then the value of the patents is potentially up to $750 million. The two composition and use patents covering cannabis extracts and methods of preparing the same were acquired through Can B's 67% owned subsidiary, Nascent Pharma, LLC, and are: (1) US 9,730,911 B2 (granted August 15, 2017) and (2) US 10,555,928 B2 (granted February 11, 2020).
HICKSVILLE, NY, Oct. 10, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Can B Corp. ( OTCQB: CANB ) (“Can B” or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, is pleased to announce its move and consolidation of its Pure Health Product operations from Lacey, WA to Colorado. This furthers Can B's corporate consolidations as it previously did with Miami and McMinville operations also relocating to Colorado.
Processing Has Already Started HICKSVILLE, NY, July 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, is pleased to announce its newly awarded contract with One Bad Moon Rising and purchase of 1.8 million pounds of biomass. To initially service the contract, Can B purchased 1.8 million pounds of biomass that is ready for immediate processing.
HICKSVILLE, NY / ACCESSWIRE / August 25, 2021 / Can B Corp. (OTCQB:CANB) ('Can B' or the 'Company'), a diversified health and wellness company specializing in the development, production, and sale of products containing hemp-derived cannabinoids, is pleased to announce it has acquired a lease for a 300,000 square foot facility to support the operations of its recently closed acquisition of assets from Music City Botanicals, in McMinnville, Tennessee. Can B has also acquired the right of first refusal and an option to outright purchase the facility during the term of the lease.
HICKSVILLE, NY, Aug. 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Can B Corp. (OTCQB: CANB) (“CAN B” or the “Company”), diversified health and wellness company specializing in the development, production, and sale of products containing hemp-derived cannabinoids, is pleased to announce its acquisition of assets, including equipment, inventory, and intellectual property, from Music City Botanicals LLC (“MCB”), based in McMinville, Tennessee. The lab and equipment will be used for isomer (Delta-8- CBD- CBG) operations. The assets have been placed in CANB's newest wholly-owned subsidiary TN Botanicals, LLC and expects to begin operations immediately.
HICKSVILLE, NY / ACCESSWIRE / August 19, 2021 / Can B Corp. (OTCQB:CANB) ('CAN B' or the 'Company'), a diversified health and wellness company specializing in the development, production, and sale of products containing hemp-derived cannabinoids, is pleased to announce its acquisition of assets, including equipment, inventory and intellectual property, from Music City Botanicals LLC ('MCB'), based in Mcminville, Tennessee. The lab and equipment will be used for isomer (Delta-8- CBD- CBG) operations.
HICKSVILLE, NY / ACCESSWIRE / August 18, 2021 / Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a health and wellness company specializing in developing, producing and selling hemp derived cannabinoid products, today announced the Company's financial results for the second quarter ended June 30, 2021 ("Q2 2021"). Key Financial and Business Highlights during and subsequent to Q2 2021 Revenue increased 96% over Q2 2020 to $0.4 million for Q2 2021 Adjusted EBITDA loss of $2.1 million (for the 1st half of 2021) Partnered with group of professional Hollywood stuntmen and world champion action sports athletes for CBD products Purchased additional equipment to increase production at its hemp facility in Colorado Management Commentary Marco Alfonsi, Can B's Chief Executive Officer, stated, "We witnessed a nice uptick in business during the quarter as elective surgeries resumed and our medical durable equipment segment benefitted.
Adds $5 Million in Processing Assets HICKSVILLE, NY / ACCESSWIRE / August 17, 2021 / Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a diversified health and wellness company specializing in the development, production and sale of products containing hemp derived cannabinoids, is pleased to announce its acquisition of assets from TWS Pharma, based in Mead, Colorado. The transaction is valued at over $5 million for hemp processing and extraction assets located in 3 buildings totaling 50,000 square feet in northeast CO.
- Strengthened Balance Sheet with $1.7 Million Cash Balance - Strong Gross Margin of 75% HICKSVILLE, NY / ACCESSWIRE / May 22, 2021 / Can B Corp. (OTCQB:CANB) ("Can B" or the "Company") a diversified health and wellness company, announced today operating and financial results for the three months ended March 31, 2021. Marco Alfonsi, Can B's Chief Executive Officer, commented, "While we experienced a decline in our revenue due to Covid-19's negative impact on markets we serve in elective surgeries and lost clients due to business closings of certain distributors, we have taken the time to maintain and strengthen our vertically integrated platform.
HICKSVILLE, NY / ACCESSWIRE / May 12, 2021 / Can B Corp. (OTCQB:CANB) ("Can B" or the "Company"), a diversified health and wellness company, is pleased to announce its recent purchases of additional equipment in order to increase production at its industrial hemp facility in Colorado. In addition to the hemp growing and cultivations already underway in CO and NY under our Botanical Biotech division, the Company is entering the industrial hemp business.